Diverticular disease of the colon does not increase risk of Repeat C. difficile infection

Journal of Clinical Gastroenterology

Volumn 47, Issue 5, 2013, Pages 426-431

  Feuerstadt, Paul ^a   Das, Rohit ^c   Brandt, Lawrence J ^b  

^a Gastroenterology Center of Connecticut   (United States)

^b Division of Gastroenterology   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

C. difficile infection; diverticular disease; recurrent

Indexed keywords

AGED; ARTICLE; ASCENDING COLON; CLOSTRIDIUM DIFFICILE INFECTION; COLON DIVERTICULOSIS; FEMALE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; RETROSPECTIVE STUDY; SIGMOID;

ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLONOSCOPY; DIVERTICULOSIS, COLONIC; DIVERTICULUM, COLON; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; INCIDENCE; MALE; RECURRENCE; RISK; TREATMENT OUTCOME;

EID: 84876418463     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318276beea     Document Type: Article

References (26)

1. Severe Clostridium difficile-Associated disease in populations previously at low risk-four states, 2005. MMWR Morb Mortal Wkly Rep. 2005;54:1201-1205
2. Feuerstadt P, Nunez JC, Rahimi E, et al. Community-Acquired Clostridium difficile-Associated disease: Characterization of an urban disease. Gastroenterology. 2010;138:S208-S209
3. Kyne L, Hamel MB, Polavaram R, et al. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis. 2002;34:346-353
4. Kelly CP, LaMont JT. Clostridium difficile-more difficult than ever. N Engl J Med. 2008;359:1932-1940
5. Pepin J, Valiquette L, Gagnon S, et al. Outcomes of Clostridium difficile-Associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/ 027. Am J Gastroenterol. 2007;102:2781-2788
6. Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect. 1998;40:1-15
7. Kyne L, Merry C, O'Connell B, et al. Factors associated with prolonged symptoms and severe disease due to Clostridium difficile. Age Ageing. 1999;28:107-113
8. Johnson S. Recurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomes. J Infect. 2009;58: 403-410
9. Delvaux M. Diverticular disease of the colon in Europe: Epidemiology, impact on citizen health and prevention. Aliment Pharmacol Ther. 2003;18(suppl 3):71-74
10. Parks TG. Natural history of diverticular disease of the colon. Clin Gastroenterol. 1975;4:53-69
11. Tedesco FJ, Gordon D, Fortson WC. Approach to patients with multiple relapses of antibiotic-Associated pseudomembranous colitis. Am J Gastroenterol. 1985;80:867-868
12. Buchner AM, Sonnenberg A. Medical diagnoses and procedures associated with Clostridium difficile colitis. Am J Gastroenterol. 2001;96:766-772
13. Thanjan ASW, Anand N, Yoon S, et al. Is Clostridium difficile infection (Cdi) more difficult to eradicate in patients with diverticulosis? Am J Gastroenterol. 2008;103:S169
14. Lipp MJ, Pagovich OE, Rabin D, et al. Prevalence of diverticulosis in recurrent Clostridium difficile infection. World J Gastroenterol. 2010;16:345-347
15. Charlson ME, Ales KL, Simon R, et al. Why predictive indexes perform less well in validation studies. Is it magic or methods? Arch Intern Med. 1987;147:2155-2161
16. Buchner AM, Sonnenberg A. Medical diagnoses and procedures associated with Clostridium difficile colitis. Am J Gastroenterol. 2001;96:766-772
17. Pepin J, Alary ME, Valiquette L, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis. 2005;40:1591-1597
18. McFarland LV, Surawicz CM, Rubin M, et al. Recurrent Clostridium difficile disease: Epidemiology and clinical characteristics. Infect Control Hosp Epidemiol. 1999;20:43-50
19. Garey KW, Dao-Tran TK, Jiang ZD, et al. A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics. J Hosp Infect. 2008; 70:142-147
20. Pepin J, Valiquette L, Alary ME, et al. Clostridium difficileassociated diarrhea in a region of Quebec from 1991 to 2003: A changing pattern of disease severity. CMAJ. 2004;171:466-472
21. Zar FA, Bakkanagari SR, Moorthi KM, et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-Associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007;45:302-307
22. Leclair MA, Allard C, Lesur O, et al. Clostridium difficile infection in the intensive care unit. J Intensive Care Med. 2010; 25:23-30
23. Das R, Feuerstadt P, Brandt LJ. Glucocorticoids are associated with increased risk of short-Term mortality in hospitalized patients with Clostridium difficile-Associated disease. Am J Gastroenterol. 2010;105:2040-2049
24. Lee YS. Diverticular disease of the large bowel in Singapore. An autopsy survey. Dis Colon Rectum. 1986;29:330-335
25. Chia JG, Wilde CC, Ngoi SS, et al. Trends of diverticular disease of the large bowel in a newly developed country. Dis Colon Rectum. 1991;34:498-501
26. Carethers JM. One colon lumen but two organs. Gastroenterology. 2011;141:411-412